SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Baldanti F)
 

Search: WFRF:(Baldanti F) > Conversion of monoc...

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages

Marcotte, Harold (author)
Karolinska Institutet,Karolinska Inst, Sweden
Cao, Yunlong (author)
Changping Lab, Peoples R China; Peking Univ, Peoples R China
Zuo, Fanglei (author)
Karolinska Inst, Sweden
show more...
Simonelli, Luca (author)
Univ Svizzera italiana, Switzerland
Sammartino, Jose Camilla (author)
Fdn Ist Ricovero & Cura Carattere Sci IRCCS Policl, Italy
Pedotti, Mattia (author)
Univ Svizzera italiana, Switzerland
Sun, Rui (author)
Karolinska Institutet,Karolinska Inst, Sweden
Cassaniti, Irene (author)
Fdn Ist Ricovero & Cura Carattere Sci IRCCS Policl, Italy
Hagbom, Marie (author)
Linköpings universitet,Avdelningen för molekylär medicin och virologi,Medicinska fakulteten
Piralla, Antonio (author)
Fdn Ist Ricovero & Cura Carattere Sci IRCCS Policl, Italy
Yang, Jinxuan (author)
Chinese Acad Sci, Peoples R China
Du, Likun (author)
Karolinska Institutet,Karolinska Inst, Sweden
Percivalle, Elena (author)
Fdn Ist Ricovero & Cura Carattere Sci IRCCS Policl, Italy
Bertoglio, Federico (author)
Tech Univ Carolo Wilhelmina Braunschweig, Germany
Schubert, Maren (author)
Tech Univ Carolo Wilhelmina Braunschweig, Germany
Abolhassani, Hassan (author)
Karolinska Institutet,Karolinska Inst, Sweden
Sherina, Natalia (author)
Karolinska Institutet,Karolinska Inst, Sweden
Guerra, Concetta (author)
Univ Svizzera italiana, Switzerland
Borte, Stephan (author)
Hosp St Georg, Germany; Hosp St Georg, Germany
Rezaei, Nima (author)
Univ Tehran Med Sci, Iran
Kumagai-Braesch, Makiko (author)
Karolinska Institutet,Karolinska Inst, Sweden
Xue, Yintong (author)
Peking Univ, Peoples R China
Su, Chen (author)
Peking Univ, Peoples R China
Yan, Qihong (author)
Karolinska Institutet,Chinese Acad Sci, Peoples R China,Karolinska Inst, Sweden
He, Ping (author)
Chinese Acad Sci, Peoples R China
Groenwall, Caroline (author)
Karolinska Institutet,Karolinska Univ Hosp, Sweden
Klareskog, Lars (author)
Karolinska Institutet,Karolinska Univ Hosp, Sweden
Calzolai, Luigi (author)
European Commiss, Italy
Cavalli, Andrea (author)
Univ Svizzera italiana, Switzerland
Wang, Qiao (author)
Fudan Univ, Peoples R China
Robbiani, Davide F. (author)
Univ Svizzera italiana, Switzerland
Hust, Michael (author)
Tech Univ Carolo Wilhelmina Braunschweig, Germany
Shi, Zhengli (author)
Chinese Acad Sci, Peoples R China
Feng, Liqiang (author)
Chinese Acad Sci, Peoples R China
Svensson, Lennart (author)
Karolinska Institutet,Linköpings universitet,Avdelningen för molekylär medicin och virologi,Medicinska fakulteten,Karolinska Inst, Sweden
Chen, Ling (author)
Guangzhou Lab, Peoples R China
Bao, Linlin (author)
Inst Lab Anim Sci, Peoples R China; Peking Union Med Coll, Peoples R China; Natl Ctr Technol Innovat Anim Model, Peoples R China
Baldanti, Fausto (author)
Fdn Ist Ricovero & Cura Carattere Sci IRCCS Policl, Italy; Univ Pavia, Italy
Xiao, Junyu (author)
Changping Lab, Peoples R China
Qin, Chuan (author)
Inst Lab Anim Sci, Peoples R China; Peking Union Med Coll, Peoples R China; Natl Ctr Technol Innovat Anim Model, Peoples R China
Hammarstrom, Lennart (author)
Karolinska Institutet,Karolinska Inst, Sweden
Yang, Xinglou (author)
Chinese Acad Sci, Peoples R China
Varani, Luca (author)
Univ Svizzera italiana, Switzerland
Xie, Xiaoliang Sunney (author)
Changping Lab, Peoples R China; Peking Univ, Peoples R China
Pan-Hammarstrom, Qiang (author)
Karolinska Inst, Sweden
show less...
 (creator_code:org_t)
NATL ACAD SCIENCES, 2024
2024
English.
In: Proceedings of the National Academy of Sciences of the United States of America. - : NATL ACAD SCIENCES. - 0027-8424 .- 1091-6490. ; 121:3
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The emergence of Omicron lineages and descendent subvariants continues to present a severe threat to the effectiveness of vaccines and therapeutic antibodies. We have previ- ously suggested that an insufficient mucosal immunoglobulin A (IgA) response induced by the mRNA vaccines is associated with a surge in breakthrough infections. Here, we further show that the intramuscular mRNA and/or inactivated vaccines cannot suffi- ciently boost the mucosal secretory IgA response in uninfected individuals, particu- larly against the Omicron variant. We thus engineered and characterized recombinant monomeric, dimeric, and secretory IgAl antibodies derived from four neutralizing IgG monoclonal antibodies (mAbs 01A05, rmAb23, DXP-604, and XG014) targeting the receptor-binding domain of the spike protein. Compared to their parental IgG antibod- ies, dimeric and secretory IgAl antibodies showed a higher neutralizing activity against different variants of concern (VOCs), in part due to an increased avidity. Importantly, the dimeric or secretory IgAl form of the DXP-604 antibody significantly outperformed its parental IgG antibody, and neutralized the Omicron lineages BA.1, BA.2, and BA.4/5 with a 25- to 75-fold increase in potency. In human angiotensin converting enzyme 2 (ACE2) transgenic mice, a single intranasal dose of the dimeric IgA DXP-604 conferred prophylactic and therapeutic protection against Omicron BA.5. Thus, dimeric or secre- tory IgA delivered by nasal administration may potentially be exploited for the treatment Iand prevention of Omicron infection, thereby providing an alternative tool for combating immune evasion by the current circulating subvariants and, potentially, future VOCs.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Keyword

ISA; SARS COV-2; Omicron; antibody engineering; antibody therapy

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view